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The glycan-binding protein galectin-1 controls survival
of epithelial cells along the crypt-villus axis of small
intestine
C Muglia1, N Mercer1, MA Toscano2, M Schattner3, R Pozner3,4, JP Cerliani2, R Papa Gobbi1, GA Rabinovich2,4,5 and GH Docena*,1,5
Intestinal epithelial cells serve as mechanical barriers and active components of the mucosal immune system. These cells
migrate from the crypt to the tip of the villus, where different stimuli can differentially affect their survival. Here we investigated,
using in vitro and in vivo strategies, the role of galectin-1 (Gal-1), an evolutionarily conserved glycan-binding protein, in
modulating the survival of human and mouse enterocytes. Both Gal-1 and its specific glyco-receptors were broadly expressed in
small bowel enterocytes. Exogenous Gal-1 reduced the viability of enterocytes through apoptotic mechanisms involving
activation of both caspase and mitochondrial pathways. Consistent with these findings, apoptotic cells were mainly detected at
the tip of the villi, following administration of Gal-1. Moreover, Gal-1-deficient (Lgals1/)mice showed longer villi compared with
their wild-type counterparts in vivo. In an experimental model of starvation, fasted wild-type mice displayed reduced villi and
lower intestinal weight compared with Lgals1/ mutant mice, an effect reflected by changes in the frequency of enterocyte
apoptosis. Of note, human small bowel enterocytes were also prone to this pro-apoptotic effect. Thus, Gal-1 is broadly expressed
in mucosal tissue and influences the viability of human and mouse enterocytes, an effect which might influence the migration of
these cells from the crypt, the integrity of the villus and the epithelial barrier function.
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The intestinal mucosa is continuously challenged by a variety
of antigens from the diet and from commensal or pathogenic
microorganisms, which should be carefully discriminated in
order to either mount an active immune response or to
promote immune tolerance.1 Epithelial cells, which are critical
in this regulatory pathway, differentiate from stem cells
located in the crypts and undergo a highly regulated
maturation program as they migrate along the crypt-villus
axis, forming a dynamic renewing tissue that maintains the
integrity of the intestinal epithelium.2 As enterocytes migrate
upwards along the axis, they acquire a mature absorptive
phenotype, and are finally eliminated by apoptosis at the top of
the villus. Several signaling cascades control cellular pro-
liferation, differentiation, migration and apoptosis of entero-
cytes.3 Furthermore, different metabolites (iron, vitamins,
amino acids, carbohydrates and lipids) and relevant enzymes
including acyl-CoA synthetase serve as regulatory mediators
that contribute to enterocyte renewal in the human intestine.3
However, the cellular and molecular mechanisms underlying
the regulation of apoptosis of senescent enterocytes and
maintenance of mucosal homeostasis, are still poorly under-
stood.
Galectin-1 (Gal-1), an evolutionarily conserved b-gala-
ctoside-binding protein, has key roles in a variety of
physiologic and pathologic processes.4,5 These functions
include suppression of T-cell responses through selective
induction of TH1 and TH17 cell apoptosis
4,5 and activation of
tolerogenic circuits on dendritic cells.6 These glycosylation-
dependent functions account for the capacity of this lectin to
dampen inflammation in autoimmune, chronic and acute
inflammatory disorders,4,7–9 and to favor immune escape of
certain types of cancer.10,11
Gal-1 is expressed in different portions of the human and
mouse gastrointestinal tract,12–14 and similar to other mem-
bers of the galectin family, has been implicated in different
intestinal disorders.7,14–17 Gal-1 expression is downregulated
in a mouse model of 2,4,6-trinitrobenzene sulfonic acid
(TNBS)-induced colits and its therapeutic administration
contributes to inhibition of TH1 and pro-inflammatory cyto-
kines (TNF, IL-1b, IL-12 and IFN-g), and remission of the
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clinical and histopathologic signs of inflammatory bowel
disease.7 On the other hand, overexpression of Gal-1 has been
linked to the progression of human colon carcinomas.12,16
The present study was aimed at elucidating the role of Gal-1
in the intestinal epithelial cell compartment. We found that
Gal-1 binds to human and mouse enterocytes where it signals
apoptosis through a caspase-dependent mechanism, leading
to depolarization of the mitochondrial membrane and cas-
pase-3 activation. Accordingly, mice lackingGal-1 (Lgals1/)
have longer duodenal villi and exhibit a more pronounced
deleterious response upon starvation compared with wild-
type mice, suggesting that Gal-1 may be involved in overall
regulation of enterocyte turnover in the villus, thus contributing
to small bowel homeostasis.
Results
Co-expression of Gal-1 and Gal-1-binding sites in
mouse small intestine correlates with a permissive
‘glycosylation signature’. To understand the role of Gal-
1-glycan interactions in mucosal microenvironments, we first
assessed the expression of Gal-1 and specific glycan
structures in mouse small intestine. Gal-1 expression was
evaluated in intestinal cells at the mRNA and protein levels
by qRT-PCR and immunoblot analysis, respectively (Figures
1a and b). Duodenal mouse cells showed considerable
expression of this glycan-binding protein (0.8 mg/mg protein
or 3mg/g wet intestinal tissue). Gal-1 was abundant within the
lamina propria and muscularis mucosa (Figure 1c). To
determine the distribution of specific glyco-receptors that
might mediate the functions of this glycan-binding protein,
Gal-1-binding sites were assessed by flow cytometry of
mouse enterocytes using biotinylated rGal-1 (Figure 1d).
Enterocytes displayed considerable expression of glyco-
epitopes that bound exogenous rGal-1. A dose-response
curve of lectin binding analyzed by flow cytometry
demonstrated that as low as 15 ng/ml Gal-1 was sufficient
to bind cell surface glycans on enterocytes (data not
shown). Carbohydrate-dependent binding of rGal-1 was
demonstrated by co-incubation with 100mM lactose,
(Figure 1d). To determine the glycophenotype of small
intestinal tissue, we used a panel of plant lectins that bind
to specific glycan structures and determine susceptibility or
resistance to Gal-1 (Figure 1e). Consistent with the extensive
binding of Gal-1 to enterocytes in the tip of the villi, these
cells also bound peanut agglutinin (PNA), a lectin that
binds to asialo-galactose-b1-3-N-acetylgalactosamine core-1
O-glycans and marks the absence of a2-3 sialylation of core-
1 O-glycans, L-phytohemagglutinin (PHA-L), a lectin that
recognizes b1,6-N-acetylglucosamine-branched complex
N-glycans and Lycopersicon esculentum (LEL), a lectin that
recognizes polylactosamine-enriched glyco-epitopes.5 In line
with this glyco-profile, we found no specific reactivity for the
Sambucus nigra agglutinin (SNA), suggesting the absence
of a2-6 sialylated-terminal glycans on epithelial cells.
Collectively these results confirm the abundance of Gal-1
and Gal-1-binding sites within murine small intestine,
suggesting a potential role for lectin-glycan lattices in
modulating enterocyte homeostasis.
Gal-1 induces apoptotic death of mouse enterocytes. As
Gal-1 has been reported to modulate the survival of
distinct cell types, including T cells and tumor cells, through
induction of apoptosis,4,11,18,19 we examined the pro-
apoptotic effects of this lectin on enterocytes isolated from
mouse small bowel. Freshly isolated enterocytes were
incubated in the presence of 10 mM rGal-1 for 2, 4 and 16 h
and binding of annexin V was analyzed as a marker of early
apoptosis (Figure 2a). Isolated enterocytes exposed to rGal-1
showed increased annexin V staining in a time-dependent
manner. Although enterocytes spontaneously underwent
apoptosis after being extracted from the mucosa (time¼ 0)
(Figure 2a), annexin V staining intensity was higher in cells
incubated with rGal-1 as incubation time was prolonged, as
compared with controls cultured in medium alone. A
percentage of cells incubated with rGal-1 were annexin
V suggesting that a restricted population of epithelial cells
were resistant to the pro-apoptotic effects of this lectin. The
frequency of CD3þ T cells in cell extracts was below 3% in
all cases as analyzed by flow cytometry (data not shown).
Interestingly, upon incubation with rGal-1 phosphatidylserine
exposure occurred in a concentration- and saccharide-
dependent manner (Figure 2b). Apoptosis of enterocytes
was evidenced by flow cytometry using the terminal
deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) assay (Figure 2c). Enterocytes treated with rGal-1
for 16 h showed an increased percentage of TUNEL-positive
cells (51±3.5 versus 27.10±1 compared with cells cultured
with medium alone; Po 0.01). Thus, exposure to Gal-1
engages an apoptotic program in mouse primary
enterocytes.
Characterization of the Gal-1 apoptotic pathway in
enterocytes. To further understand the mechanisms
underlying Gal-1-induced cell death, isolated enterocytes
were exposed to Gal-1 in the absence or presence of the
ZVAD-FMK (benzyloxycarbonyl-Val-Ala-Asp (OMe)
fluoromethylketone), a pan-caspase inhibitor (Figure 3a).
Results showed a statistically significant inhibition of
apoptosis induced by Gal-1 in enterocytes previously
exposed to ZVAD-FMK, suggesting that Gal-1-induced cell
death proceeds through a caspase-dependent pathway. As
clearly seen, not all cells isolated from the epithelial
compartment underwent apoptosis in the presence of
rGal-1, which reflects the differential sensitivity of some
sub-populations to the effects of this glycan-binding protein.
To investigate whether caspase-3 is involved in this pathway,
cells cultured with rGal-1 for 16 h were lysed and caspase-3
activity was assessed using the specific fluorometric
substrate Ac-DEVD-AFC (N-acetyl-Asp-Glu-Val-Asp-AFC 7-
amino-4-trifluoromethyl coumarin) (Figure 3b). When
cells were exposed to rGal-1, fluorescent staining
increased in a dose-dependent manner, an effect which
was almost completely prevented by co-incubation of Gal-1
with a caspase-3-specific inhibitor (DEVD-CHO) (Figure 3b).
Our results indicate that Gal-1 signals a caspase-3-
dependent apoptotic pathway in enterocytes. To further
evaluate upstream mediators involved in this apoptotic
mechanism, we analyzed variations of the mitochondrial
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membrane potential in enterocytes exposed to rGal-1 for
16 h. A significant percentage of cells displayed reduced
mitochondrial membrane potential (higher green fluorescent
and lower red fluorescence) (Figure 3c), suggesting a role
of the mitochondrial pathway in Gal-1-induced enterocyte
apoptosis.
Figure 1 Expression of Gal-1 and Gal-1-binding sites in small bowel mouse mucosa. (a) Quantitative RT-PCR analysis of mRNA Gal-1 expression in duodenum of wild-
type and Lgals1/ mice. Results are expressed as fold increase of mRNA Gal-1 expression, standardized with mRNA b-actin expression (NA: no amplification). (b) Upper
panel: immunoblot analysis of protein extracts obtained from duodenum of wild-type and Lgals1/ mice; lower panel: immunoblotting for Gal-1 of duodenum from wild-type
mouse (sample) and known quantities of rGal-1 (200–25 ng) to build a standard curve for quantification of relative Gal-1 concentration in tissues analyzed.
(c) Immunohistochemistry of Gal-1 in duodenum of wild-type mice as revealed with a rabbit Gal-1 antiserum or non-immune rabbit serum as negative control. (d) Flow
cytometry of Gal-1 binding to isolated mouse enterocytes. Biotinylated rGal-1 and streptavidin-APC were used with (dotted lines) or without 100mM lactose (black lines). As
controls (gray lines) cells were only stained with streptavidin-APC. Percentages correspond to cells expresssing Gal-1-binding sites. (e) Glycophenotype of mouse duodenum
was assayed using biotinylated lectins: Gal-1, PHA (as an indicator of b1,6-branched complex N-glycans), PNA (indicating lack of terminal a2-3-linked sialic acid in core-1-O-
glycans), LEL (indicating poly-N-acetyl-lactosamine sequences), SNA (indicating the presence of a2-6 sialic acid linked to terminal galactose). Negative controls were carried
out by omitting incubation with the corresponding lectin. Arrows indicate lectin binding
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Exogenous Gal-1 promotes mouse enterocyte apoptosis
in vivo. To directly assess the physiologic relevance of Gal-
1-induced apoptosis in vivo, ligated loop assays were
performed. Mice were treated with a duodenal intralumenal
injection of rGal-1, saline or BSA as a control protein. After
3 h, anesthetized animals were killed, the small intestine was
excised and enterocytes were isolated. A statistically
significant induction of apoptosis was achieved with 20 mM
rGal-1 (Figure 4a). However, when mice were treated with
the same concentration of BSA or saline solution no binding
of annexin V was detected (Figure 4a). Moreover, similar
results were obtained using Lgals1/ mice, suggesting
lack of contribution of endogenous over exogenous Gal-1
in enterocyte viability. To determine whether phosphati-
dylserine exposure was accompanied by execution of a full
apoptotic program, TUNEL assay was carried out on
Figure 2 Gal-1 signals apoptosis in mouse enterocytes. (a) Epithelial cells isolated from duodenal mucosa were incubated with 10 mM rGal-1 and annexin V binding was
analyzed by flow cytometry. Left panel: enterocytes extracted at time zero (dashed line), black histogram corresponds to cells incubated with culture medium during different
time periods and gray histogram corresponds to cells incubated with Gal-1 10 mM. Right panel summarizes the results of four independent experiments; white column
corresponds to cells incubated without rGal-1 whereas dark column corresponds to cells exposed to Gal-1 (mean values±S.E.M.). Statistically significant differences Po0.05
are denoted as starred values (*). (b) Phosphatidylserine exposure induced by rGal-1. Cells were incubated for 16 h with different concentrations of Gal-1 and analyzed by
annexin V staining and flow cytometry. Data represent fold increase±S.E.M. of percentages of annexin Vþ , PI cells relative to cells incubated with medium alone. Results
correspond to eight independent experiments. Experiments were also carried out in the presence of 100mM lactose. Statistically significant differences Po0.05 are denoted
as starred values (*). (c) Apoptosis of enterocytes induced by rGal-1 as shown by TUNEL assay and flow cytometry. Cells were incubated with medium (upper left panel) or
with 10mM Gal-1 during 16 h (upper right panel). Data are representative of four independent experiments giving similar results. Data in the bottom panel show the mean
value±S.E.M. of four parallel and independent experiments (***Po0.01)
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intestinal samples by inmunofluorescence (Figure 4b). Few
apoptotic cells could be detected in loops filled with saline
(1–2 nuclei per 5 villi) or with BSA (not shown). Although few
apoptotic cells were observed within the lamina propria, most
TUNEL-positive nuclei were detected in the epithelial cell
compartment of loops filled with rGal-1. Notably, most of
TUNEL-positive epithelial cells were located in the tip of the
villi (showed by arrows). These results indicate that mouse
enterocytes are sensitive to in vivo induction of apoptosis by
Gal-1. Of note, the frequency of TUNEL-positive cells was
similar between Lgals1/ and wild-type mice filled with
saline or rGal-1 in ligated loop assays (data not shown).
Endogenous Gal-1 controls mice villus length. It has
been demonstrated that enterocytes located on the tip of the
villus undergo apoptosis and shedding, and this effect may
influence the length of the villus.20 We studied the potential
role of endogenous Gal-1 in modulating mouse enterocyte
apoptosis, and hence the villus length using duodenum from
wild-type and Lgals1/ mice. Samples were routinely fixed,
Figure 3 Mechanisms underlying Gal-1-induced enterocyte apoptosis. (a) Flow cytometry analysis of annexin V/PI staining of enterocytes cultured for 16 h with different
stimuli. Enterocytes were incubated with medium plus FBS (negative control), with medium without FBS (apoptosis positive control, with 10 mM rGal-1, with rGal-1 10mM
before incubation for 2 h with ZVAD-FMK (a pan-caspase inhibitor) or with medium before incubation for 2 h with ZVAD-FMK. Results are from one representative of four
independent experiments. The accompanying graph shows average percentage of annexin Vþ / PI cells from all experiments. Statistically significant differences of Po0.05
are denoted as starred values (*). (b) Enzymatic activity of caspase-3 was determined with the caspase-3 specific fluorometric substrate Ac-DEVD-AFC. Enterocytes were
incubated with 10mM rGal-1 for 16 h and then harvested, lysed and analyzed. DEVD-CHO is a caspase-3-specific inhibitor. Data are results of four independent experiments
(mean value±S.E.M.). *Po0.05. (c) Alteration of the mitochondrial membrane potential in enterocytes incubated for 16 h with medium alone (negative control, left dot plot) or
with 10mM rGal-1 (right dot plot). Data are results of four independent experiments. *Po0.05
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stained with haematoxilin/eosin and visualized by optical
microscopy. Although villus morphology was similar in wild-
type and Lgals1/mice, villus from Gal-1-deficient mice was
significantly longer (Po 0.002) (Figure 5a), indicating a
potential role of endogenous Gal-1 in modulating epithelial
cell survival. Of note, no significant histological differences
were observed in other organs studied (liver, kidney, heart,
thymus, lung, spleen) (data not shown). To rule out the
possibility that longer villi in Lgals1/ mice could be
associated with an increased proliferative response in the
crypts, we performed an in vivo assay with BrdU and the
binding to FITC-labeled anti-BrdU was analyzed by flow
cytometry. No statistical difference could be observed in the
percentage of BrdU-positive cells between Lgals1/ and
wild-type mice (17.1±1.8 versus 16.7±0.6, respectively)
(Figure 5b). When proliferation cell nuclear antigen (PCNA) was
analyzed by immunohistochemistry, positive cells were observed
in the crypt of all samples and no statistical difference was
observed when comparing wild-type versus Lgals1/ mice
(10.16±2.11 versus 9.58±1.08cells/crypt, respectively) (data
not shown). Thus, endogenous Gal-1 regulates villus length
through mechanisms involving modulation of cell death rather
than proliferation of epithelial cells.
Starvation differentially modulates villus length in
wild-type and Lgals1/ mice. To further evaluate the
pathophysiologic relevance of our findings, animals were
starved for 48 h as this process conditions mouse
enterocytes to engage apoptotic programs.21 Compared
with fasted Lgals1/ mice, fasted wild-type mice showed
reduced villus length and a diminished small intestine weight
in response to starvation (Figures 6a–c). However, no
significant differences were observed in villi length and
intestine weight between fasted and ad libitum fed Lgals1/
mice. Enterocyte apoptosis was also evaluated using
annexin V staining. The percentage of annexin V positive
cells was significantly higher in wild-type fasted mice as
compared with Lgals1/ counterparts, consistent with
reduced villus length and intestinal weight data (Figure 6d).
In addition, we observed an increase in induction of Lgals1
transcript (1.25-fold increase) and Gal-1 protein (1.7-fold
increase) in fasted versus ad libitum fed wild-type mice as
determined by qRT-PCR (Figure 6e) and immunoblot
analysis (data not shown). These results demonstrate that
endogenous Gal-1 is required for epithelial cell survival and
response to starvation.
Gal-1 induces apoptosis of human enterocytes. Given
the potential biomedical implications of our findings, we then
sought to examine the effect of Gal-1 in the induction of
apoptosis of human yeyunum enterocytes. Surgical
specimens of normal human small bowel were employed
Figure 4 Gal-1-mediated induction of enterocyte apoptosis in vivo. (a) Flow cytometry analysis of annexin V and PI staining in cells obtained from duodenal ligated loops.
Results correspond to cells isolated from either wild-type or Lgals1/ mice that had ligated loops filled with saline, 10 mM rGal-1, 20mM rGal-1 or the same concentration of
BSA as indicated. The histogram shows representative results out of four separate experiments: *Po0.05. (b) TUNEL assay of ligated loops corresponding to wild-type and
Lgals1/ mice filled with saline or rGal-1 20mM. TUNEL-positive nuclei appear in cyan (arrows). Background shows DAPI staining. Results are representative of three
independent experiments
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and enterocytes were detached from the mucosa and
analyzed by fluorescence microscopy. Apoptosis was
assessed by staining isolated cells with ethidium bromide
and acrydine orange upon incubation with rGal-1 (Figure 7a).
The basal percentages of apoptotic and necrotic cells were
highly variable among samples (20±10% apoptotic cells and
10±8% necrotic cells). Notably, incubation of isolated
enterocytes with rGal-1 for 16 h yielded a highly significant
percentage of apoptotic cells (90±2%). When assessed by
flow cytometry, Gal-1 induced apoptosis of human
enterocytes in a dose-dependent manner (Figures 7b and c).
These results indicate that human enterocytes are highly
sensitive to the pro-apoptotic effect of this glycan-binding
protein.
Discussion
The homeostasis of the intestinal epithelium requires tight
control and balance of the different processes of proliferation,
differentiation, migration and apoptosis. This coordination
requires intervention of multiple synchronized pathways. The
epithelial compartment of the gut encompasses a high cell
turnover and the preservation of normal morphology and
function relies on a delicate balance between cell proliferation
and death.20 Several mechanisms have been proposed to
operate in enterocyte maturation and apoptosis along the
crypt-villus axis. In fact, there are two main compartments
where apoptosis is physiologically relevant: at the crypt level,
to remove excess or unwanted stem cells, and at the tip of the
villus to limit their life span and control villus length.20
As protein-glycan interactions have recently emerged as
critical mediators of intestinal cell physiology and pathol-
ogy,22,23 here we investigated the role of Gal-1 in the induction
of apoptosis of intestinal epithelial cells, mainly in senescent
epithelial cells located near the top of the villus.20 We provide
evidence on the role of Gal-1-glycan lattices in human and
mouse enterocyte apoptosis. Induction of apoptosis by this
glycan-binding protein has been widely described in a variety
of cell subsets.4,5,10 Susceptibility of T cells to Gal-1-induced
cell death has been well established and characterized in
normal and pathological conditions, and it has been proposed
to be regulated via Fas-dependent or -independent path-
ways.5,18,19 B cell lymphoma cells,24 and non-immune cells
such as Leydig cells,25 prostate cancer cells,26 breast cancer
cells and trophoblast tumors,27 have also found to be targets
of the pro-apoptotic effects of Gal-1. Regarding intestinal
Figure 5 Role of endogenous Gal-1 in regulating villi length. (a) Haematoxylin-eosin staining of intestinal samples from wild-type (n¼ 15) and Lgals1/ (n¼ 15) mice.
*Po0.002. Ten sections per duodenum were analyzed. (b) Analysis of anti-BrdU-FITC and 7-AAD by flow cytometry of isolated intestinal epithelial cells obtained from wild
type and Lgals1/ mice
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cells, human colonic Caco-2 cells have been proposed to be
susceptible to Gal-1-induced cell death, although the precise
mechanisms and physiologic relevance of these findings have
not yet been characterized.28 In the present study we provide
the first evidence showing a role for Gal-1 in modulating the
survival of human and mouse enterocytes isolated from the
small bowel; this mechanism could influence the maturation
process of these cells during their migration from the crypt to
the tip of the villus. In this regard, it appears that the
glycosylation machinery generates a differential array of cell
surface glycans along the crypt/villus axis, whichmakes these
cells sensitive to Gal-1-induced cell death. The synthesis of
these glycan structures occurs via a complex and highly
regulated process involving glycosyltransferases and glyco-
sidases.4 Mechanisms of Gal-1-mediated death have been
shown to vary among different cell types.11,18,19,25 Using
in vitro assays, we demonstrated using isolated epithelial cells
that apoptosis is dependent on caspase activation, through
the intrinsic mitochondrial pathway. Paclik et al.28 reported
a calpain-dependent, caspase-independent, induction of
apoptosis by Gal-1 in the tumor Caco-2 cell line.29 These
results could be relevant in the context of genes that control
apoptosis during colorectal cancer.30
Interestingly, we found that Gal-1 induces apoptosis of a
discrete population of enterocytes. TUNEL-positive cells were
detected in the tip of the villi when apoptosis was induced in
vivo following administration of rGal-1. Strikingly, we found
that Lgals1/ mice exhibited longer villi as compared with
wild type mice, which did not appear to be related to
differences in cell proliferation. Moreover, when mice were
subjected to physiologic stress (fasting during 48 h), animals
devoid of Gal-1 did not significantly afford reduction of villus
length and small bowel weight, as compared with their
wild-type counterpart.
The glycosylation profile of cell surface glycoproteins and
glycolipids can differ considerably among different gut cell
populations, when compared with similar cell subsets from
other organs and tissues.31 This effect might be probably
related to the particular tolerogenic microenvironment pre-
valent in the gut, which imposes a differential glyco-profile
Figure 6 Role of endogenous Gal-1 in regulating epithelial cell survival in vivo following starvation. Wild-type and Lgals1/ mice were starved during 48 h and intestinal
specimens were analyzed. (a) Haematoxylin-eosin staining of representative small bowel longitudinal sections of wild-type and Lgals1/mice corresponding to ad libitum fed
mice and fasted mice. Magnification  20 (a and b) and  10 (c and d). (b) Statistical analysis corresponding to villi length (*Po 0.05). Data are expressed as mean
values±S.E.M. (n¼ 10). (c) Statistical analysis corresponding to small bowel weight (*Po 0.05). Data are expressed as mean values±S.E.M. (n¼ 7). (d) Annexin V
staining of enterocytes collected from wild-type and Lgals1/ fasted and ad libitum fed mice. Right: statistical analysis of results obtained with three mice of each group
(*Po0.05). (e) Quantitative RT-PCR analysis of mRNA Gal-1 expression in duodenum of wild-type ad libitum fed and fasted mice. Results are expressed as fold increase of
mRNA Gal-1 expression, standardized with b-actin mRNA expression (*Po0.05)
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through enhanced activity of sialyltransferases.22,31 In the
present work, by using biotinylated lectins, we found that
enterocytes display a glycosylation profile characterized by
the absence of a2-3 sialylation of core-1 O-glycans (PNAþ
cells), b1,6-branched complex N-glycans (L-PHAþ cells) and
poly-N-acetyl-lactosamine sequences (LELþ cells) as well as
the absence of a2,6-linked terminal sialic acid (SNA cells).
Interestingly, this phenotype is consistent with a glycosylation
signature permissive for Gal-1 binding and subsequent cell
death, as it has been demonstrated for the T-cell compart-
ment.5 However, this glycophenotype may differ in an
inflammatory setting where the balance between cell pro-
liferation and apoptosis is altered.7 Although different mole-
cular pathways have been proposed,32,33 the mechanisms
underlying cell death during inflammatory processes still
remain uncertain. In this regard, the influence of glycosylation
and the regulatory effect of glycan-binding proteins have not
been carefully studied in the epithelial cell compartment.
In this study, we showed that Gal-1 induces apoptosis both
in vitro and in vivo, a process that was prevented by addition of
the specific disaccharide lactose. This suggests that cell
viability may be dependent on the glycosylation status of
epithelial cell surface receptors and may be spatio-temporally
regulated during the differentiation of these cells along the
crypt-villus axis. Although basal levels of apoptosis were
observed once epithelial cells underwent anoikis, a con-
centration- and time-dependent induction of cell death was
observed in cells exposed in vivo (ligated loop assay) or
in vitro to rGal-1.
Regarding the source of endogenous Gal-1, this lectin has
been reported to be distributed within the whole mammalian
digestive tract. Human gut expresses Gal-1 both in the
epithelial compartment and in the lamina propria.13 In the
mouse gut, this lectin is expressed diffusely in the lamina
propria as well as in the muscle layer.34 However, the
production of Gal-1 in the epithelial compartment is rather
controversial.15,34,35 Mathieu et al.14 reported a differential
distribution of this lectin that is highly dependent on themouse
strain analyzed. We found that intestinal cells belonging to
mouse 129/SvJ strain express substantial amounts of Gal-1
and Gal-1-binding sites.
Remarkably, Gal-1 substantially decreased in TNBS-
induced colitis, an effect that positively correlated with
inappropriate mucosal T cell accumulation and resistance of
lamina propria T cells to apoptosis,7 suggesting that Gal-1-
glycan lattices may have a role in maintaining epithelial-
immune homeostasis and integrity of intestinal mucosa. Our
results indicate that Gal-1 serves as a key soluble factor
involved in regulation of epithelial cell turnover and gut
homeostasis. Lgals1/ mice showed longer villi and wild-
type mouse small intestine showed an altered response upon
starvation. Overall, these results suggest that endogenous
Gal-1 is implicated in the regulation of enterocyte viability
under physiologic or stress situations. Remarkably, cell
proliferation rate was found to be equivalent in wild-type and
Lgals1/ mice, suggesting that this process does not
constitute a compensatory mechanism to restore the homeo-
static environment.
Figure 7 Gal-1 triggers apoptotic death in human enterocytes. (a) Ethidium bromide and acridine orange staining of human enterocytes by fluorescence microscopy. Live
enterocytes at initial time (left panel); isolated enterocytes exposed to 10 mM rGal-1 for 16 h where a majority of apoptotic enterocytes (brilliant green or orange nucleus) can be
observed (middle panels) and necrotic enterocytes (right panel). (b) Flow cytometry analysis of annexin V and PI staining of enterocytes incubated with medium alone or 10 mM
rGal-1. (c) Mean values of percentages of annexin V positive cells. *Po0.05. The results shown are representative of four independent experiments
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In conclusion, our findings indicate for the first time that
endogenous Gal-1 can execute an apoptotic program on
human and mouse enterocytes, through activation of the
mitochondrial pathway of cell death and this effect is more
pronounced once the cell reaches the tip of the villus. This
process may be critical in maintaining the integrity of the villus
and sustaining the epithelial barrier function, thus favoring
immune cell homeostasis and nutrient absorption. However,
many questions still need to be addressed to further dissect
the role of Gal-1-glycan interactions in different pathologic
conditions of the gastrointestinal tract in which apoptosis
contributes to disease pathogenesis, or is involved in the
normal clearance of damaged cells (cancer, IBD, celiac
disease or infectious diseases).32,33,36,37
Materials and Methods
Intestinal epithelial cells. Cells were obtained from human and mouse small
bowel. Wild-type and Lgals1/ mice used in this study were of 129/SvJ
background. Lgals1/ mice were kindly provided by F Poirier (Institut Jacques
Monod, Paris). Mice were bred at the animal facility of the Faculty of Exact Sciences,
National University of La Plata according to institutional guidelines. The duodenum
was washed, opened longitudinally and incubated for 10min at 4 1C in buffer A
(Hank’s buffered saline solution (HBSS) supplemented with 100 IU/ml penicillin,
100mg/ml streptomycin and 2% equine serum) with 1 mM dithiotreitol and then, with
fresh buffer A plus 0.5 mM EDTA for 20min at 37 1C with vigorous shaking. Cells
were immediately resuspended in RPMI supplemented with 5% fetal bovine serum
(FBS), penicillin/streptomycin and gentamicin. All protocols were approved by the
Ethics Committee of the School of Exact Sciences, National University of La Plata.
Intestinal human resection specimens were obtained with the consent of patients
undergoing gut transplantation at Fundacio´n Favaloro (Buenos Aires, Argentina)
according to Institutional Review Board guidelines for the use of human tissue.
Tissue was collected onto ice-cold HBSS supplemented with penicillin/streptomycin
until use. The mucosal layer was mechanically removed, washed with HBSS and
incubated in HBSS/penicillin/streptomycin plus 0.5 mM EDTA. Cells were pelleted,
resuspended in RPMI supplemented with 5% FBS, penicillin/streptomycin and used
immediately.
Immunoblot analysis. Tissues were homogenized and cells were lysed as
described previously.38 Samples were assayed for the presence of Gal-1 by using a
12% SDS-PAGE under reducing conditions (total protein load was 30mg per lane)
and immunoblotted with rabbit specific antiserum obtained as described before
(dilution 1 : 3000), followed by horseradish peroxidase-conjugated goat anti-rabbit
IgG. Membranes were stripped and probed for b-actin (rabbit anti-mouse b-actin
antibody, diluted 1 : 4000, AbCam Cambridge, UK) as a loading control.
Immunoblots were visualized with the ECL Plus System (GE Healthcare, Bucks,
UK) according to manufacturer’s instructions. The bands were scanned and
quantified using the Adobe Photoshop CS software (version 8.0.1).
Real time RT-PCR. Total RNA extraction was performed using the NucleoSpin
RNA II kit (Macherey-Nagel, Dueren, Germany). Reverse transcription was
performed using random primers and MMLV-Reverse transcriptase (Invitrogen,
Carlsbad, CA, USA). qPCR was performed following manufacturer’s protocol using
the iCycler thermal cycler (Bio-Rad, Hercules, CA, USA). Primer sequences for
Gal-1 were used as described.6 Fold difference was represented by the ratio of the
normalized value of each sample to that of mouse b-actin.39
Histology and immunohistochemistry. Mouse intestines were fixed in
5% neutral-buffered formalin and embedded in paraffin. Samples were cut and
mounted onto positive-charged glass slides and heated at 60 1C for 30min. Briefly,
xylene and ethanol were used to de-paraffinize and endogenous peroxidase activity
was blocked with 3% H2O2/methanol. Antigen retrieval was performed in buffer
citrate (pH 6.0) and slides were microwaved. Non-specific sites were blocked with
1% BSA in PBS and incubated with primary and secondary antibodies.
Counterstaining with 10% hematoxylin was performed and sections were
mounted with Eukit. For routine histological examination, the length of duodenal
villi was assessed using an ocular micrometer. The length of 10 well-oriented villi
with both side-crypts visible was measured per cross-section, and the mean length
was calculated. At least five sections per animal were analyzed.
PCNA was assessed as a nuclear marker of DNA synthesis and proliferation,40
using a specific anti-PCNA antibody (Santa Cruz, Santa Cruz, CA, USA), followed
by an anti-rabbit IgG-biotin and strepavidin-HRP (Sigma, St. Louis, MO, USA).
Immunostaining was then revealed using 3,30-diaminobenzidine tetrahydrochloride
(DAB) chromogen (DAKO, Glostrup, Denmark).
Lectin histochemistry was performed using biotinylated lectins as the primary
binding reagent: SNA, PNA, Lycopersicon esculentum lectin (LEL) and Phaseolus
vulgaris agglutinin (PHA) were all from Vector Labs (Edelberry; Burlingame, CA,
USA) and used at a concentration of 25 mg/ml. Recombinant Gal-1 (rGal-1) (3mg/
ml) was biotinylated as described.5,18 Streptavidin-HRP (DAKO) was then used as a
secondary reagent and DAB was employed for the staining. Controls were
performed by omitting the biotinylated lectins.
Immunohistochemistry for Gal-1 was carried out using a rabbit antiserum specific
to Gal-1 obtained as described (dilution 1/3000). Primary antibody was incubated
overnight at 4 1C and then goat anti-rabbit IgG conjugated to HRP (DAKO) was
used for 1 h at 37 1C (dilution 1/3000). Finally, sections were incubated with DAB.
Control with non-immune serum as primary antibody was performed.
TUNEL assay was performed essentially as described by the manufacturer
(Promega, Madison, WI, USA). Nuclei were counterstained with DAPI and apoptotic
cells were visualized by fluorescence microscopy.
Galectin binding assay. Gal-1 binding to enterocytes was performed by
flow cytometry using decreasing concentrations of biotinylated Gal-1 ranging from
15mg/ml–1.5 ng/ml followed by addition of streptavidin-APC (BD Pharmingen,
Franklin Lakes, NJ, USA). Controls were included either by omitting the biotinylated
lectin or by performing binding assays in the presence of 100mM lactose.
Apoptosis assays. Freshly isolated enterocytes were incubated in RPMI 1640
medium supplemented with 5% FBS, penicillin/streptomycin at 37 1C in a humidified
5% CO2 atmosphere with different concentrations of rGal-1 during 2, 4 or 16 h.
Saccharide-dependent binding of Gal-1 to enterocytes was assessed in the
presence of 100mM lactose as described.18 To analyze the mechanisms underlying
epithelial cell death, cells were pre-treated with the pan-caspase inhibitor ZVAD-
FMK (R&D Systems, Minneapolis, MN, USA). Controls included dimethyl sulfoxide
(vehicle). As positive controls, cell death was induced with serum-deprived medium
or with actinomycin D.
Apoptotic cells were also visualized by fluorescence microscopy.41 Cell
suspension was mixed with an equal volume of a solution containing 0.01%
ethidium bromide and 0.003% acridine orange. A Nikon Eclipse E400 microscope
(Nikon, Tokyo, Japan) was used for visualization. Apoptosis was quantitatively
analyzed by flow cytometry using double staining with annexin V-FITC/propidium
iodide (PI). Briefly, cells were washed twice with PBS, and then incubated for 20min
with annexin V at 4 1C in the dark. Early (annexin Vþ /PI) and late (annexin
Vþ /PIþ ) apoptotic events were quantified. Fluorescence was detected using a
FACSCalibur cytometer (BD Pharmigen).
TUNEL assay (Promega) was also used to study late apoptosis by flow
cytometry according to manufacturer’s instructions. Briefly, cells were washed, fixed
with 4% paraformaldehyde in PBS, permeabilized with ethanol, and then incubated
with TdT enzyme plus deoxinucleotides and fluorescein-12-dUTP for 1 h at 37 1C.
Cells were washed, stained with PI and analyzed by flow cytometry (FACSCalibur
cytometer). Fluorescein-12-dUTP incorporation results in green fluorescence within
the nucleus of apoptotic cells; PI stains both apoptotic and non-apoptotic cells.
Fluorometric analysis of caspase-3 activity. Cells were lysed in ice-cold
lysate buffer (10mM EDTA, 50mM Tris-HCl (pH 7.4), 150mM sodium chloride, 1%
Triton X100, 2mM phenylmethylsulfonyl fluoride, 2 mM sodium orthovanadate,
10mg/ml leupeptin and 2mg/ml aprotinin) and the protein content was quantified
with the bicinchoninic acid kit (Pierce BCA Protein Assay, Pierce, Rockford, IL,
USA), using BSA as standard. Lysates were incubated with the caspase-3-specific
substrate Ac-DEVD-AFC (Biomol International, Plymouth Meeting, PA, USA).
Briefly, the fluorogenic AFC is released from the substrate by the caspase-3 action
and it is spectrofluorometrically detected at 505 nm after excitation (400 nm). The
arbitrary fluorescence units were normalized to the total protein content of the
sample. In order to evaluate the specificity of the reaction, a control including the
caspase-3 specific inhibitor Ac-DEVD-CHO (N-acetyl-Asp-Glu-Val-Asp-CHO
aldehyde) (Biomol International) was performed.
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Analysis of the mitochondrial pathway by flow cytometry. The
Mitochondrial Permeability Detection Kit (MTt-E-j, Biomol International) was
used to analyze the mitochondrial membrane potential according to manufacturer’s
instructions. Briefly, 5,50,6,60-tetrachloro-1,10,3,30-tetraethyl-benzamidazolocarbo-
cyanin iodide (JC-1) accumulates in healthy mitochondria giving rise to a red
fluorescent signal. When the mitochondrial membrane potential declines as a
consequence of the induction of apoptosis, a green fluorescence can be detected in
mitochondria due to dye distribution within the cell.42,19 Cells were incubated with
the MTt-E-j reagent for 15min at 37 1C, and after washing they were resuspended
in PBS. Fluorescence was detected by flow cytometry.
In vivo assessment of Gal-1-induced apoptosis in epithelial
cells. Young male mice (N¼ 5 per group), 25–30 g of weight, were fasted
overnight and anaesthetized by intraperitoneal injection of ketamine (100mg/kg)
and xylacine (5 mg/kg). The ligated intestinal loop technique was performed as
follows: a small longitudinal incision was practiced in the lower abdomen and a 2 cm
section of small intestine from duodenum was clamped. Next, 100ml of saline
solution (control) or saline plus rGal-1 (20 mM) or BSA (20 mM) were injected in
independent loops in the same animal. The abdominal wall was then sutured.
During the procedure mice were kept warm on a 37 1C warming pad and
anesthetized. Three hours later animals were killed by cervical dislocation and the
different loops were individually processed. Apoptosis was evaluated by flow
cytometry using annexin V/ PI staining and by TUNEL assay in paraffin-embedded
tissue sections as previously described.
Proliferation assay. Proliferation was determined using bromodeoxyuridine
(BrdU) In-Situ Detection Kit (BD Pharmingen) according to manufacturer’s instructions.
Briefly, wild-type and Lgals1/ mice were given an intraperitoneal injection of 1mg/ml
BrdU in phosphate buffer (pH 7.4). Mice were killed 24 h later by cervical dislocation;
enterocytes were isolated and further permeabilized. Cells were cultured with anti-BrdU
labeled with FITC and fluorescence was analyzed by flow cytometry.
Starvation experiment. Adult wild-type (n¼ 14) and Lgals1/ (n¼ 14)
mice (weight 25–30 g) were used. All animals received water ad libitum. For each
group seven animals were fed mouse chow ad libitum (control groups) whereas the
remaining seven mice were starved for 48 h. Finally, all animals were killed and the
small bowel was analyzed.
Statistical analysis. Comparison of two groups (means) was performed by
using the one-way ANOVA and Student’s t test for the comparison of paired
samples. Results represent the mean±S.E.M. All results with Po0.05 were
considered statistically significant.
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